| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 290.30M | — |
| Operating expense | — | — |
| Net income | 53.20M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, RSLBF returned -33.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -20.8% |
| 1 year | -33.7% |
| 5 years | +114.5% |
| 10 years | +29.1% |
| All-time high | $36.85 (Jul 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in RSLBF would be worth today ›No. RaySearch Laboratories AB (publ) has not paid a dividend in the past 12 months.
RaySearch Laboratories AB (publ) is part of the Healthcare sector.
RaySearch Laboratories AB (publ) has a market cap of 561.80M USD, based on the latest quote.
RaySearch Laboratories AB (publ) is scheduled to report earnings on Nov 3, 2026.
